GOLGA7: A Potential Drug Target and Biomarker (G51125)

Target Name: GOLGA7

NCBI ID: G51125

GOLGA7

GOLGA7: A Potential Drug Target and Biomarker

GOLGA7 (GOLGA3AP1) is a protein that is expressed in various tissues throughout the body. It is a member of the GOLGA family of proteins, which are known for their role in intracellular signaling. GOLGA7 has been shown to play a role in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. As a result, GOLGA7 has emerged as a promising drug target and biomarker.

The GOLGA family of proteins are characterized by their ability to localize to the endoplasmic reticulum (ER) and to regulate the levels of intracellular proteins. GOLGA7 is a 21-kDa protein that is predominantly expressed in the ER. It is composed of a unique transmembrane domain and a cytoplasmic tail that is involved in its stability and localization to the ER.

GOLGA7 has been shown to play a role in intracellular signaling by regulating the levels of various cytoplasmic proteins. For example, GOLGA7 has been shown to regulate the levels of the protein Pyh2, which is involved in cell signaling and cell cycle progression. In addition, GOLGA7 has been shown to regulate the levels of the protein Fyn, which is involved in the immune response and cell signaling.

GOLGA7 has also been shown to play a role in the development and progression of various diseases. For example, GOLGA7 has been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. In addition, GOLGA7 has been shown to be involved in the development of cancer, including melanoma and breast cancer.

As a result of its involvement in intracellular signaling and the development of various diseases, GOLGA7 has emerged as a promising drug target. Several studies have shown that inhibiting GOLGA7 can lead to therapeutic effects in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

In addition to its potential as a drug target, GOLGA7 has also been shown to be a potential biomarker. The ability of GOLGA7 to be expressed and regulated in various tissues makes it a promising marker for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

GOLGA7 has been shown to be involved in the regulation of cellular processes that are important for disease development and progression. As a result, its potential as a drug target and biomarker makes it an attractive target for further research and development. Further studies are needed to fully understand the role of GOLGA7 in disease and to develop effective therapies based on its potential as a drug target and biomarker.

Protein Name: Golgin A7

Functions: May be involved in protein transport from Golgi to cell surface. The ZDHHC9-GOLGA7 complex is a palmitoyltransferase specific for HRAS and NRAS

The "GOLGA7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GOLGA7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets